Your browser doesn't support javascript.
loading
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study.
Morgan, Evan; Suresh, Anupama; Ganju, Akaansha; Stover, Daniel G; Wesolowski, Robert; Sardesai, Sagar; Noonan, Anne; Reinbolt, Raquel; VanDeusen, Jeffrey; Williams, Nicole; Cherian, Mathew A; Li, Zaibo; Young, Gregory; Palettas, Marilly; Stephens, Julie; Liu, Joseph; Luff, Amanda; Ramaswamy, Bhuvaneswari; Lustberg, Maryam.
Affiliation
  • Morgan E; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Suresh A; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Ganju A; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Stover DG; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Wesolowski R; Department of Internal Medicine, Riverside Methodist Hospital, Columbus, Ohio, USA.
  • Sardesai S; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Noonan A; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Reinbolt R; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • VanDeusen J; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Williams N; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Cherian MA; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Li Z; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Young G; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Palettas M; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Stephens J; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Liu J; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Luff A; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
  • Ramaswamy B; Stefanie Spielman Comprehensive Breast Cancer, The Ohio State University, Columbus, OH, USA.
  • Lustberg M; Division of Medical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, OH, USA.
World J Surg Oncol ; 18(1): 11, 2020 Jan 14.
Article de En | MEDLINE | ID: mdl-31937323
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Marqueurs biologiques tumoraux / Antigène CD274 / Tumeurs du sein triple-négatives Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Middle aged Langue: En Journal: World J Surg Oncol Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Marqueurs biologiques tumoraux / Antigène CD274 / Tumeurs du sein triple-négatives Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Middle aged Langue: En Journal: World J Surg Oncol Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni